Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 29 01 2019
accepted: 23 04 2019
revised: 21 04 2019
pubmed: 12 5 2019
medline: 12 2 2020
entrez: 12 5 2019
Statut: ppublish

Résumé

Difficult-to-treat rheumatoid arthritis (RA) is a significant clinical problem despite no clear definition. We aimed to provide clinical characteristics and associated comorbidities of RA patients in relation to disease control. RA characteristics and physician-recorded comorbidities were analyzed in a sample of 1937 RA patients. Patients treated for RA for 5.2 y (IQR, 2.1-11.3) were classified as difficult-to-control when presenting with DAS28-ESR > 3.2 despite previous use of at least 2 csDMARDs. A comparison of demographic and RA-related characteristics between difficult-to-treat and low disease activity patients (DAS28-ESR ≤ 3.2) was performed. Comorbidity burden was assessed by calculating Rheumatic Diseases Comorbidity Index (RDCI). Logistic regression model was constructed for difficult-to-control disease. Hypertension (46.9% (95%CI, 44.7-49.2)), coronary artery disease (CAD) (18.5% (95%CI, 16.8-20.3)), and diabetes (14.4% (95%CI, 12.9-16.0)) were the most prevalent conditions in RA patients. When compared with the adequate control group, difficult-to-control patients were increasingly burdened with hypertension (52.7% (95%CI, 47.5-57.8) vs. 42.0% (95%CI, 36.6-47.6); p = 0.006), cardiovascular diseases (24.2% (95%CI, 20.1-28.9) vs. 11.1% (95%CI, 8.0-15.1); p < 0.001), respiratory system diseases (7.0% (95%CI, 4.8-10.2) vs. 3.3% (95%CI, 1.8-5.9); p = 0.03) and gastroduodenal ulcers (2.3% (95%CI, 1.2-4.4) vs. 0.3% (95%CI, 0.1-1.8); p = 0.04). Patients with higher RDCI had lower chance to obtain low disease activity (OR 0.69 (95%CI, 0.61-0.79); p < 0.001). In multivariate analysis, RDCI was independently associated with difficult-to-control disease (OR 1.46 (95%CI, 1.21-1.76); p < 0.001). RA patients suffer from a variety of comorbidities. Cardiovascular and respiratory system diseases occur twice as often in difficult-to-control patients. RDCI may provide a valuable tool in evaluating a risk for difficult-to-control RA. Key Points • Hypertension, coronary artery disease and diabetes are the most prevalent comorbidities in rheumatoid arthritis. • Cardiovascular and respiratory tract diseases as well as gastroduodenal ulcers are more common among difficult-to-control patients, when compared with subjects with adequately controlled RA. • Rheumatic Diseases Comorbidity Index is an independent predictor for difficult-to-control RA.

Identifiants

pubmed: 31076943
doi: 10.1007/s10067-019-04579-1
pii: 10.1007/s10067-019-04579-1
doi:

Substances chimiques

Antirheumatic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2473-2481

Références

Arthritis Res Ther. 2006;8(3):R66
pubmed: 16600016
Scand J Rheumatol. 2010;39(5):353-9
pubmed: 20615160
Rheumatology (Oxford). 2013 Oct;52(10):1809-17
pubmed: 23813577
Scand J Rheumatol. 2013;42(6):451-6
pubmed: 23826623
Ann Rheum Dis. 2014 Jan;73(1):62-8
pubmed: 24095940
Semin Arthritis Rheum. 2014 Apr;43(5):613-26
pubmed: 24231065
Ann Rheum Dis. 2015 Jun;74(6):998-1003
pubmed: 24458537
Arthritis Res Ther. 2014 Apr 14;16(2):R94
pubmed: 24731866
Arthritis Care Res (Hoboken). 2015 May;67(6):865-72
pubmed: 25186344
Arthritis Res Ther. 2015 Aug 20;17:219
pubmed: 26290061
PLoS One. 2016 Jan 12;11(1):e0146991
pubmed: 26757209
Arthritis Res Ther. 2016 Jan 28;18:33
pubmed: 26818851
Arthritis Rheumatol. 2017 Mar;69(3):529-541
pubmed: 27696788
Ann Rheum Dis. 2017 Jan;76(1):17-28
pubmed: 27697765
J Mark Access Health Policy. 2017 Jul 5;5(1):1345580
pubmed: 28740623
Front Med (Lausanne). 2018 Feb 16;5:39
pubmed: 29503820
RMD Open. 2018 Mar 17;4(1):e000615
pubmed: 29593881
Ann Rheum Dis. 2018 Dec;77(12):1705-1709
pubmed: 30194273
Reumatologia. 2018;56(4):228-233
pubmed: 30237627
Arch Med Sci. 2019 Jan;15(1):134-140
pubmed: 30697263
Biomed Res Int. 2019 Jan 10;2019:6107217
pubmed: 30733963
J Thorac Imaging. 1993 Winter;8(1):54-62
pubmed: 8418318

Auteurs

Bogdan Batko (B)

Department of Rheumatology, J. Dietl Specialist Hospital, 1 Skarbowa St, 31-121, Krakow, Poland. bpbatko@gmail.com.

Karol Urbański (K)

Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, Krakow, Poland.

Jerzy Świerkot (J)

Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland.

Piotr Wiland (P)

Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland.

Filip Raciborski (F)

Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.

Mariusz Jędrzejewski (M)

GfK Polonia, Warsaw, Poland.

Mateusz Koziej (M)

Department of Anatomy, Jagiellonian University School of Medicine, Krakow, Poland.

Marta Cześnikiewicz-Guzik (M)

Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, Krakow, Poland.
Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Tomasz J Guzik (TJ)

Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, Krakow, Poland.
BHF Centre of Research Excellence, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Marcin Stajszczyk (M)

Rheumatology and Autoimmune Diseases Department, Silesian Rheumatology Center, Ustron, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH